Skip to main content

Table 1 Demographics and disease characteristics

From: Treatment of glioblastoma multiforme with “classic” 4:1 ketogenic diet total meal replacement

Gender (M, %)

 

6 (75)

Age, years

40s

n = 5

60s

n = 3

Race

Caucasian/white

5

Caucasian/Hispanic

1

Asian Indian

2

Group1

Group 1

4

Group 2

4

GBM primary/secondary

Primary

6

Secondary

2 (both in group 2)

IDH 12 mutational status

Negative

6

Unknown

2

MGMT3 promoter methylation status

Negative

5

Positive

2

Unknown

1

  1. 1Group 1, newly diagnosed GBM, KD concurrent with radiation and temozolomide; group 2, recurrent GBM
  2. 2IDH isocitrate dehydrogenase
  3. 3MGMT O6-methylguanine methyltransferase promoter methylation